<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696835</url>
  </required_header>
  <id_info>
    <org_study_id>2018_73</org_study_id>
    <secondary_id>2019-A02517-50</secondary_id>
    <nct_id>NCT04696835</nct_id>
  </id_info>
  <brief_title>fNIRS in Pediatric Hearing Aids</brief_title>
  <acronym>FNIRS</acronym>
  <official_title>Use of Near-infrared Functional Spectroscopy (fNIRS) in the Evaluation of Hearing Rehabilitation in Children With Hearing Aid(s)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation William Demant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot phase. Monocentric, non-controlled, non-randomized, open-label study evaluating the&#xD;
      capacity of the functional near-infrared functional neuroimaging (fNIRS) technique to&#xD;
      translate temporal cortical activity in response to a speech stimulus in normo-hearing and&#xD;
      deaf children with cochlear implants.&#xD;
&#xD;
      Hemodynamic changes are expected to be observed that indicate brain activity following the&#xD;
      stimuli, resulting in a change in the concentration of oxygenated hemoglobin (HbO) and&#xD;
      deoxygenated hemoglobin (HbR) recorded by the fNIRS.&#xD;
&#xD;
      The use of the FNIRS in the evaluation of hearing aid effectiveness could contribute to a&#xD;
      more adapted management of childhood hearing loss since conventional methods in young&#xD;
      children are not adapted to the needs of children with hearing loss.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenated haemoglobin concentration (HbO)</measure>
    <time_frame>Baseline (at inclusion)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Deoxygenated haemoglobin concentration (HbR)</measure>
    <time_frame>Baseline (at inclusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbO Concentration</measure>
    <time_frame>At 3 months, 6 months, 12 months and 24 months</time_frame>
    <description>Evolution of the variation in HbO concentration in the group of infants fitted with a device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbR Concentration</measure>
    <time_frame>At 3 months, 6 months, 12 months and 24 months</time_frame>
    <description>Evolution of the variation in HbR concentration in the group of infants fitted with a device.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>children with hearing aids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>speech audiometry</intervention_name>
    <description>65dB, 55dB or 75dB SPL speech audiometry</description>
    <arm_group_label>children with hearing aids</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Group A: Infants and toddlers 3-18 months of age who are normal hearing.&#xD;
&#xD;
          -  Group B: Infants and toddlers aged 3 to 18 months with sensorineural hearing loss&#xD;
             fitted with a unilateral or bilateral hearing aid with optimized adjustments by the&#xD;
             hearing healthcare professional.&#xD;
&#xD;
          -  Socially insured subject&#xD;
&#xD;
          -  Parents or guardians who have given their consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical condition that does not allow for research compliance.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe VINCENT, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christophe VINCENT, PU-PH</last_name>
    <phone>0320445962</phone>
    <phone_ext>+33</phone_ext>
    <email>christophe.vincent@chru-lille.Fr</email>
  </overall_contact>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 5, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NIRS</keyword>
  <keyword>hearing aid</keyword>
  <keyword>pediatrics</keyword>
  <keyword>cochlear implant</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>neuroimaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

